BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17726521)

  • 1. Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha.
    Willberg CB; Ward SM; Clayton RF; Naoumov NV; McCormick C; Proto S; Harris M; Patel AH; Klenerman P
    PLoS One; 2007 Aug; 2(8):e791. PubMed ID: 17726521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI; Brown GR; Thiele DL
    J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6.
    Barrie MB; Stout HW; Abougergi MS; Miller BC; Thiele DL
    J Immunol; 2004 May; 172(10):6453-9. PubMed ID: 15128837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic lymphocyte expression of dipeptidyl peptidase I-processed granzyme B and perforin induces hepatocyte expression of serine proteinase inhibitor 6 (Serpinb9/SPI-6).
    Stout-Delgado HW; Getachew Y; Miller BC; Thiele DL
    J Immunol; 2007 Nov; 179(10):6561-7. PubMed ID: 17982045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.
    Kaser A; Enrich B; Ludwiczek O; Vogel W; Tilg H
    Clin Exp Immunol; 1999 Oct; 118(1):71-7. PubMed ID: 10540162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
    J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.
    Vanhoutte VJ; McAulay KA; McCarrell E; Turner M; Crawford DH; Haque T
    Immunology; 2009 Aug; 127(4):577-86. PubMed ID: 19604308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.
    Ando K; Hiroishi K; Kaneko T; Moriyama T; Muto Y; Kayagaki N; Yagita H; Okumura K; Imawari M
    J Immunol; 1997 Jun; 158(11):5283-91. PubMed ID: 9164947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
    Roth E; Pircher H
    J Immunol; 2004 Feb; 172(3):1588-94. PubMed ID: 14734739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepadnaviral infection augments hepatocyte cytotoxicity mediated by both CD95 ligand and perforin pathways.
    Guy CS; Wang J; Michalak TI
    Liver Int; 2010 Mar; 30(3):396-405. PubMed ID: 19912529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
    J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction.
    Gremion C; Grabscheid B; Wölk B; Moradpour D; Reichen J; Pichler W; Cerny A
    J Virol; 2004 Feb; 78(4):2152-7. PubMed ID: 14747581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection.
    Balkow S; Kersten A; Tran TT; Stehle T; Grosse P; Museteanu C; Utermöhlen O; Pircher H; von Weizsäcker F; Wallich R; Müllbacher A; Simon MM
    J Virol; 2001 Sep; 75(18):8781-91. PubMed ID: 11507223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection.
    Lee JY; Chae DW; Kim SM; Nam ES; Jang MK; Lee JH; Kim HY; Yoo JY
    J Viral Hepat; 2004 Mar; 11(2):130-5. PubMed ID: 14996347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID
    J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
    Yang S; Haluska FG
    J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.